Skip to content

Japan’s Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients

By asianet

Saitama Medical University International Medical Center, one of Japan’s leading hospitals for the treatment of oncology, cardiology, and stroke cases, has joined the TriNetX Network to utilize global real-world data to better understand rare diseases, treatments, and outcomes, as well as provide additional clinical trial opportunities to its patients. Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg “Novel therapies may … Continued

Japan’s Omi Medical Center, Seikoukai, Becomes the First Healthcare Organization in Western Japan to Sign a Partnership Agreement with TriNetX to Increase Participation in Multi-National Clinical Trials

By asianet

Omi Medical Center, part of the Seikoukai Social Medical Corporation and one of Japan’s leading institutions in the use of advanced medical technologies, announced it is partnering with TriNetX to increase its exposure and participation in multi-national industry-sponsored clinical trials. Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg “The use of Japanese pharmaceuticals has dropped from 20% to less than … Continued

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

By asianet

Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity. Logo – https://mma.prnewswire.com/media/751177/Aji_BioPharma_Logo.jpg In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma succeeded in developing a highly functional artificial RNA … Continued

Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board

By asianet

Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup is the former Secretary, Department … Continued

Nippon Express Singapore Receives IATA CEIV Pharma Certification for Changi International Airport Facility

By asianet

Nippon Express (Singapore) Pte. Ltd. (hereinafter “NX Singapore”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired IATA CEIV Pharma (*) certification for its facility in the Free Trade Zone (FTZ) at Singapore Changi International Airport, effective Wednesday, January 17, 2023. Logo: https://kyodonewsprwire.jp/img/202302152976-O1-mlDJ2Ge9 Photo: https://kyodonewsprwire.jp/prwfile/release/M103866/202302152976/_prw_PI2fl_2k7X0YXf.jpg The pharmaceutical/medical sector, one of Singapore’s priority industries, has … Continued

B dot Medical to Install Ultra-compact Proton Therapy System at Thammasat University in Thailand

By asianet

– Responding to Growing Needs for Urban-type Proton Therapy in Thailand – B dot Medical Inc. and Thammasat University, a leading national university in Thailand, have signed a memorandum of understanding to install the ultra-compact proton therapy system developed by B dot Medical. The agreement encourages installing the advanced cancer treatment system in Thailand, where … Continued

Nippon Express Obtains GDP Certification of Compliance with WHO Standards at 2 Domestic Locations: West Japan Pharmaceutical Center and Kyushu Pharmaceutical Center

By asianet

– Storage and Transport Offered in Two Temperature Ranges, Following East Japan Pharmaceutical Center – Nippon Express Co., Ltd. (hereinafter “Nippon Express”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired Good Distribution Practice (GDP) certification for its West Japan Pharmaceutical Center (Neyagawa City, Osaka Prefecture) and Kyushu Pharmaceutical Center (Kitakyushu City, Fukuoka Prefecture), … Continued

BGI COLOTECT 3.0 demonstrates higher colorectal cancer detection sensitivity than FIT

By asianet

COLOTECT 3.0, a multi-target fecal DNA test outperforms fecal immunochemical tests (FIT) in terms of detection of colorectal cancer and advanced precancerous lesions BGI Genomics, a global life sciences company providing integrated solutions of precision medicine, presented case-control study data on its COLOTECT 3.0 non-invasive colorectal cancer screening test at the 2023 ASCO Gastrointestinal Cancers … Continued

SONIRE Announces First Patient Enrolled in Randomized Phase 2 Study of Its Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan

By asianet

SONIRE Therapeutics Inc. (hereinafter referred to as “SONIRE”), based in Tokyo, announces that it has commenced a randomized phase 2 study for the treatment of unresectable pancreatic cancer with SONIRE’s next-generation High-Intensity Focused Ultrasound (HIFU) therapy system (development code: Suizenji). Logo: https://kyodonewsprwire.jp/prwfile/release/M107547/202301272458/_prw_PI1fl_1823Ko1T.jpg The 5-year survival rate of pancreatic cancer is very low at 8.5%, and … Continued